首页> 外文期刊>Surgical oncology >Regional nodal staging for early stage colon cancer in the era of endoscopic resection and N.O.T.E.S.
【24h】

Regional nodal staging for early stage colon cancer in the era of endoscopic resection and N.O.T.E.S.

机译:内镜切除和N.O.T.E.S.时代的早期结肠癌的区域淋巴结分期

获取原文
获取原文并翻译 | 示例
           

摘要

Advanced endoscopic technologies and techniques capable of providing localized resection of colonic primaries are entering clinical practice. As much as Natural Orifice Transluminal Endoscopic Surgery (N.O.T.E.S.) may ultimately provide for transmural resection with narrow margins, intraluminal techniques such as endoscopic submucosal resection can now effect excision of early stage tumors from within the colon. However, the limit on the application of these approaches is oncological providence as current staging requires en bloc mesenteric resection in every case to ensure that adequate nodal assessment is assured. Furthermore, this requirement is also a limiting factor on the advance of innovative procedures such as Single-Incision Laparoscopic Surgery and N.O.T.E.S.-hybrid techniques as these approaches, while likely adept at the definitive management of the primary, have limitations regarding their ability to provide full base mesenteric resection (due mostly to constraints on retraction capacity as well as operating field space and exposure). Therefore a means to accurately and efficiently identify those patients who are truly node negative (and so in whom radical mesenteric lymphadenectomy could be avoided) would allow all of these techniques to advance with a clear focus on address of the primary. This review analyses the current state of the art of regional staging in the colonic mesentery in place of formal lymphadenectomy. It includes deliberation of both preoperative non-invasive testing as well as novel means of employing N.O.T.E.S. approaches to allow direct determination of lymph node status (in particular that of sentinel nodes) by either rapid histopathological examination or by emerging technologies such as Optical Coherence Tomography that may provide optical or 'virtual' biopsy.
机译:先进的内窥镜技术和能够对结肠原发进行局部切除的技术正在进入临床实践。尽管自然孔腔腔内镜手术(N.O.T.E.S.)最终可能提供狭窄边缘的透壁切除术,但腔内技术(例如内窥镜粘膜下切除术)现在可以从结肠内切除早期肿瘤。但是,由于目前的分期要求在每种情况下进行整体肠系膜切除术,以确保有足够的淋巴结评估,因此这些方法的应用受到肿瘤学的限制。此外,此要求也是诸如单切口腹腔镜手术和NOTES混合技术等创新程序前进的限制因素,因为这些方法虽然可能擅长于原发性的最终管理,但在提供完整的功能方面存在局限性肠系膜基础切除术(主要是由于牵缩能力以及手术视野和暴露区域的限制)。因此,一种准确,有效地识别真正淋巴结阴性的患者的方法(因此可以避免行彻底的肠系膜淋巴结清扫术)将允许所有这些技术的发展,并将重点明确放在原发灶上。这篇综述分析了结肠肠系膜替代正式淋巴结清扫术的区域分期技术现状。它包括对术前非侵入性测试以及采用N.O.T.E.S.可以通过快速组织病理学检查或新兴技术(例如可以提供光学或“虚拟”活检的光学相干断层扫描)直接确定淋巴结状态(特别是前哨淋巴结)的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号